Sivelestat
From Self-sufficiency
| File:Sivelestat.png | |
| Systematic (IUPAC) name | |
|---|---|
|
N-{2-[({4-[(2,2-dimethylpropanoyl)oxy]phenyl}sulfonyl)amino]benzoyl}glycine | |
| Clinical data | |
| Routes of administration | IV |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | 127373-66-4 |
| ATC code | none |
| PubChem | CID 107706 |
| Chemical data | |
| Formula | C20H22N2O7S |
| Molar mass | 434.46 g/mol[[Script error: No such module "String".]] |
| Script error: No such module "collapsible list". | |
Sivelestat (INN, research name ONO 5046, marketed as Elaspol) is an inhibitor of human neutrophil elastase.[1]
It is commonly used in the treatment of acute respiratory failure.[2]
Synthesis
K. Imaki, Y. Arai, T. Okegawa, U.S. Patent 5,017,610 (1991).
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />
 |
This pharmacology-related article is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Pages with broken file links
- Drugs with non-standard legal status
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Articles containing unverified chemical infoboxes
- Enzyme inhibitors
- Pharmacology stubs
- 2Fix
